James R. Eltringham
- Genetics top 5%
- Glioma Diagnosis and Treatment 4
- Otorhinolaryngology top 5%
- Ophthalmology top 5%
- Glaucoma and retinal disorders 2
-
- Brain Metastases and Treatment 4
-
- Immune Cell Function and Interaction 4
-
- Ovarian cancer diagnosis and treatment 3
-
- Neuroendocrine Tumor Research Advances 2
-
- Electron Spin Resonance Studies 2
-
- Ultrasound and Hyperthermia Applications 2
James R. Eltringham
24 papers receiving 763 citations
Peers
Comparison fields: 5 of 70
- Genetics 245
- Otorhinolaryngology 96
- Ophthalmology 89
- Oncology 199
- Endocrinology, Diabetes and Metabolism 118
Countries citing papers authored by James R. Eltringham
This map shows the geographic impact of James R. Eltringham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Eltringham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Eltringham more than expected).
Fields of papers citing papers by James R. Eltringham
This network shows the impact of papers produced by James R. Eltringham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Eltringham. The network helps show where James R. Eltringham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James R. Eltringham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 128 | |
| 2 | 1992 | 32 | |
| 3 | Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study. | 1986 | 15 |
| 4 | 1985 | 43 | |
| 5 | 1984 | 1 | |
| 6 | 1983 | 1 | |
| 7 | 1983 | 37 | |
| 8 | 1978 | 27 | |
| 9 | 1977 | 12 | |
| 10 | 1976 | 22 | |
| 11 | 1975 | 16 | |
| 12 | Immunodeficiency in Hodgkin disease. | 1975 | 3 |
| 13 | 1975 | 43 | |
| 14 | 1975 | 41 | |
| 15 | 1973 | 15 | |
| 16 | 1973 | 94 | |
| 17 | 1971 | 8 | |
| 18 | 1971 | 127 | |
| 19 | 1970 | 8 | |
| 20 | Early secondary disease in the Rhesus monkey. I. A comparative histopathologic study. | 1969 | 50 |
About James R. Eltringham
James R. Eltringham is a scholar working on Genetics, Reproductive Medicine and Biophysics, having authored 24 papers that have together received 864 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (4 papers), Immune Cell Function and Interaction (4 papers), Ovarian cancer diagnosis and treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Electron Spin Resonance Studies (2 papers), Ultrasound and Hyperthermia Applications (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Genetics (245 citations), Otorhinolaryngology (96 citations) and Ophthalmology (89 citations). James R. Eltringham has collaborated with scholars based in United States. Frequent co-authors include Eli Glatstein, Malcolm A. Bagshaw, Don R. Goffinet, Luis F. Fajardo, Harmon J. Eyre, Joseph P. Kriss, S. McHardy-Young, John Stewart, Joseph M. Quagliana and Muhyi Al‐Sarraf. Their work appears in journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.